Non-human primate (NHP) lung models for SARS-CoV-2 variant and therapeutics testing
Closed Solicitation Posted
- Solicitation number
- 75N95021Q00392
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks offers for 600 EpiAirway 3D respiratory epithelial non-human primate microtissues and 600 EpiAlveolar 3D small airway non-human primate microtissues to be used for SARS-CoV-2 variant and therapeutics testing. The National Institutes of Health National Institute on Drug Abuse requires delivery to the National Center for Advancing Translational Sciences in Rockville, Maryland, with inspection and acceptance performed on site. Offers are due by September 8, 2021 and must be submitted electronically to the contracting officer.
There are no set-aside restrictions, making this a full and open competition under NAICS code 325414. The place of performance is within the United States. No current contractors or incumbents are identified. Potential offerors must include total shipping costs in their quotes for the 1,200 microtissues, with inspection and acceptance to occur upon delivery to the stated location on or before the specified due date.
Notice text
**Please see attached combined synopsis/solicitation**
Files
| File | Type | Posted |
|---|---|---|
| F_CSS_Comp Posting w atchmnts.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity